| Mabry Health Care | |
| 1340 N Grundy Quarles Hwy, Gainesboro, Tennessee 38562 | |
| (931) 268-0291 | |
| Name | Mabry Health Care |
|---|---|
| Location | 1340 N Grundy Quarles Hwy, Gainesboro, Tennessee |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 80 |
| Occupancy Rate | 47.25% |
| Medicare ID (CCN) | 445272 |
| Legal Business Name | Thomas J Mabry & Assoc Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1891568804 |
| Organization Name | WATERS OF GAINESBORO LLC |
| Address | 1340 N Grundy Quarles Hwy, Gainesboro, TN 38562 |
| Phone Number | 931-268-0291 |
News Archive
By creating diseased liver cells from a small sample of human skin, scientists have for the first time shown that stem cells can be used to model a diverse range of inherited disorders. The University of Cambridge researchers' findings, which will hopefully lead to new treatments for those suffering from liver diseases, were published today in The Journal of Clinical Investigation.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the insurance industry, have again invested over $2 Million to support Anpac's "Cancer Differentiation Analysis" (CDA) technology.
Enzo Biochem, Inc., announced today that it has streamlined its operations, which is anticipated to result in a reduction in annualized operating expenses of more than $4 million beginning in the fiscal 2011 first quarter. These initiatives are also expected to result in increased gross margins. The Company believes that the operating cost reductions, which affect all of its operating businesses as well as corporate overhead, will result in Enzo generating positive cash flow from operations in 2011.
A new model could help predict the risk of impending preterm birth, avoiding the adverse and costly effects of overtreatment or misdiagnosis.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
By creating diseased liver cells from a small sample of human skin, scientists have for the first time shown that stem cells can be used to model a diverse range of inherited disorders. The University of Cambridge researchers' findings, which will hopefully lead to new treatments for those suffering from liver diseases, were published today in The Journal of Clinical Investigation.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the insurance industry, have again invested over $2 Million to support Anpac's "Cancer Differentiation Analysis" (CDA) technology.
Enzo Biochem, Inc., announced today that it has streamlined its operations, which is anticipated to result in a reduction in annualized operating expenses of more than $4 million beginning in the fiscal 2011 first quarter. These initiatives are also expected to result in increased gross margins. The Company believes that the operating cost reductions, which affect all of its operating businesses as well as corporate overhead, will result in Enzo generating positive cash flow from operations in 2011.
A new model could help predict the risk of impending preterm birth, avoiding the adverse and costly effects of overtreatment or misdiagnosis.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 23.31 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.66 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 39.34 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.22 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.73 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.5 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.4 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 28.15 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.92 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 5.8 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.71 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 41.79 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.89 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 92.48 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 80.27 | 82.93 |
News Archive
By creating diseased liver cells from a small sample of human skin, scientists have for the first time shown that stem cells can be used to model a diverse range of inherited disorders. The University of Cambridge researchers' findings, which will hopefully lead to new treatments for those suffering from liver diseases, were published today in The Journal of Clinical Investigation.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the insurance industry, have again invested over $2 Million to support Anpac's "Cancer Differentiation Analysis" (CDA) technology.
Enzo Biochem, Inc., announced today that it has streamlined its operations, which is anticipated to result in a reduction in annualized operating expenses of more than $4 million beginning in the fiscal 2011 first quarter. These initiatives are also expected to result in increased gross margins. The Company believes that the operating cost reductions, which affect all of its operating businesses as well as corporate overhead, will result in Enzo generating positive cash flow from operations in 2011.
A new model could help predict the risk of impending preterm birth, avoiding the adverse and costly effects of overtreatment or misdiagnosis.
› Verified 7 days ago
Mabry Health Care Location: 1340 N Grundy Quarles Hwy, Gainesboro, Tennessee 38562 Phone: (931) 268-0291 |